• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性α1A 肾上腺素受体拮抗剂司洛多辛在输尿管结石药物排石治疗中的疗效。

Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones.

机构信息

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

出版信息

Int J Urol. 2011 Sep;18(9):672-4. doi: 10.1111/j.1442-2042.2011.02810.x. Epub 2011 Jun 26.

DOI:10.1111/j.1442-2042.2011.02810.x
PMID:21707766
Abstract

Recently, we reported that α1A adrenoceptor (AR) is the main participant in phenylephrine-induced human ureteral contraction. We therefore decided to carry out a prospective randomized study to evaluate the effects of silodosin, a selective α1A AR antagonist, as a medical expulsive therapy for ureteral stones. A total of 187 male patients, who were referred to our department for the management of symptomatic unilateral ureteral calculi of less than 10 mm, were randomly divided into two groups: group A (92 patients), who were instructed to drink 2 L of water daily, and group B (95 patients), who received the same instruction and were also given silodosin (8 mg/daily) for a maximum of 8 weeks. Expulsion rate, mean expulsion time and need for analgesics were examined. Overall, the mean expulsion time was 15.19 ± 7.14 days for group A and 10.27 ± 8.35 days for group B (P = 0.0058). In cases involving distal ureteral stones, the mean expulsion time was 13.40 ± 5.90 and 9.29 ± 5.91 days, respectively (P = 0.012). For stones of 1-5 mm in diameter, the mean expulsion time was 14.28 ± 6.35 and 9.56 ± 8.45 days, respectively (P = 0.017). For stones of 6-9 mm in diameter, the stone expulsion rate was 30.4% and 52.2% (P = 0.036), and the mean expulsion time was 21.00 ± 9.9 and 11.33 ± 8.31 days, respectively (P = 0.038). Herein, we report the first on silodosin in the management of ureteral lithiasis. Our findings suggest that silodosin might have potential as a medical expulsive therapy for ureteral stones.

摘要

最近,我们报道了α1A 肾上腺素能受体(AR)是去氧肾上腺素诱导人输尿管收缩的主要参与者。因此,我们决定进行一项前瞻性随机研究,评估选择性α1A AR 拮抗剂 silodosin 作为输尿管结石的医学排出疗法的效果。共有 187 名男性患者因单侧输尿管结石小于 10mm 而就诊于我院,他们被随机分为两组:A 组(92 例),嘱其每日饮水 2L;B 组(95 例),给予相同的指导,并接受 silodosin(每日 8mg)治疗,最长 8 周。检查排石率、平均排石时间和需要使用镇痛药的情况。总的来说,A 组的平均排石时间为 15.19 ± 7.14 天,B 组为 10.27 ± 8.35 天(P = 0.0058)。在涉及输尿管下段结石的情况下,平均排石时间分别为 13.40 ± 5.90 和 9.29 ± 5.91 天(P = 0.012)。对于直径为 1-5mm 的结石,平均排石时间分别为 14.28 ± 6.35 和 9.56 ± 8.45 天(P = 0.017)。对于直径为 6-9mm 的结石,排石率分别为 30.4%和 52.2%(P = 0.036),平均排石时间分别为 21.00 ± 9.9 和 11.33 ± 8.31 天(P = 0.038)。在此,我们首次报道了 silodosin 在治疗输尿管结石中的应用。我们的研究结果表明,silodosin 可能具有作为输尿管结石的医学排出疗法的潜力。

相似文献

1
Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones.选择性α1A 肾上腺素受体拮抗剂司洛多辛在输尿管结石药物排石治疗中的疗效。
Int J Urol. 2011 Sep;18(9):672-4. doi: 10.1111/j.1442-2042.2011.02810.x. Epub 2011 Jun 26.
2
Administration of the selective alpha 1A-adrenoceptor antagonist silodosin facilitates expulsion of size 5-10 mm distal ureteral stones, as compared to control.与对照组相比,给予选择性 α1A-肾上腺素能受体拮抗剂西洛多辛可促进排出 5-10mm 大小的远端输尿管结石。
Int Urol Nephrol. 2013 Jun;45(3):675-8. doi: 10.1007/s11255-013-0429-8. Epub 2013 Mar 31.
3
Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.萘哌地尔与西洛多辛在输尿管结石的医学排石治疗中的比较:一项日本男性患者的随机对照研究。
Int J Urol. 2011 Nov;18(11):792-5. doi: 10.1111/j.1442-2042.2011.02850.x. Epub 2011 Sep 14.
4
Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial.西洛多辛促进输尿管结石排出:一项多机构、随机、双盲、安慰剂对照试验。
Eur Urol. 2015 May;67(5):959-64. doi: 10.1016/j.eururo.2014.10.049. Epub 2014 Nov 20.
5
Role of silodosin as medical expulsive therapy in ureteral calculi: a meta-analysis of randomized controlled trials.西洛多辛在输尿管结石中的医学排石治疗作用:一项随机对照试验的荟萃分析。
Urolithiasis. 2018 Apr;46(2):211-218. doi: 10.1007/s00240-017-0974-1. Epub 2017 Apr 1.
6
The role of Silodosin as a new medical expulsive therapy for ureteral stones: a meta-analysis.西洛多辛作为输尿管结石新型药物排石疗法的作用:一项荟萃分析。
Ren Fail. 2016 Oct;38(9):1311-1319. doi: 10.1080/0886022X.2016.1215221. Epub 2016 Aug 9.
7
Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis.西洛多辛在远端输尿管结石药物排石治疗中的疗效与安全性:一项系统评价与荟萃分析
Br J Clin Pharmacol. 2016 Jan;81(1):13-22. doi: 10.1111/bcp.12737. Epub 2015 Sep 21.
8
Efficacy of Silodosin in Expulsive Therapy for Distal Ureteral Stones: A Randomized Double-blinded Controlled Trial.西洛多辛在远端输尿管结石排石治疗中的疗效:一项随机双盲对照试验。
Urol J. 2016 Jun 28;13(3):2666-71.
9
Medical expulsive therapy for distal ureteric stones: tamsulosin versus silodosin.远端输尿管结石的药物排石治疗:坦索罗辛与西洛多辛的比较
Arch Ital Urol Androl. 2014 Jun 30;86(2):103-7. doi: 10.4081/aiua.2014.2.103.
10
Role of tamsulosin, tadalafil, and silodosin as the medical expulsive therapy in lower ureteric stone: a randomized trial (a pilot study).坦索罗辛、他达拉非和西洛多辛作为输尿管下段结石药物排石疗法的作用:一项随机试验(一项初步研究)。
Urology. 2015 Jan;85(1):59-63. doi: 10.1016/j.urology.2014.09.022.

引用本文的文献

1
Safety and efficacy of Silodosin as medical expulsive therapy after shock wave lithotripsy in paediatric patients ‍‍with renal stones.西洛多辛用于小儿肾结石患者冲击波碎石术后药物排石治疗的安全性和有效性
Urolithiasis. 2025 May 20;53(1):95. doi: 10.1007/s00240-025-01760-x.
2
The efficacy and safety of mirabegron and α-adrenergic receptor antagonist in the treatment of distal ureteral stones: a systematic review and meta-analysis.米拉贝隆与α-肾上腺素能受体拮抗剂治疗远端输尿管结石的疗效与安全性:一项系统评价与荟萃分析。
Front Pharmacol. 2025 Mar 19;16:1517979. doi: 10.3389/fphar.2025.1517979. eCollection 2025.
3
Summary of the clinical practice guideline for the management of urinary stones, third edition.
《尿路结石管理临床实践指南》第三版总结
Int J Urol. 2025 May;32(5):462-474. doi: 10.1111/iju.70004. Epub 2025 Feb 10.
4
Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones.评价米拉贝隆或西洛多辛单独或联合应用作为医学排石疗法治疗输尿管下段结石的疗效和安全性。
Int Urol Nephrol. 2024 May;56(5):1605-1610. doi: 10.1007/s11255-023-03880-y. Epub 2023 Dec 2.
5
A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus.西洛多辛与坦索罗辛用于远端输尿管结石药物排石治疗的比较
Cureus. 2023 Oct 14;15(10):e47008. doi: 10.7759/cureus.47008. eCollection 2023 Oct.
6
Silodosin as a medical expulsive therapy for distal ureteral stones: A systematic review and meta-analysis.西洛多辛作为远端输尿管结石的药物排石疗法:一项系统评价和荟萃分析。
Indian J Urol. 2023 Jan-Mar;39(1):21-26. doi: 10.4103/iju.iju_115_22. Epub 2022 Dec 29.
7
Silodosin versus Tamsulosin for Medical Expulsive Therapy of Ureteral Stones: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.西洛多辛与坦索罗辛用于输尿管结石的药物排石治疗:一项更新的随机对照试验的系统评价和荟萃分析。
Medicina (Kaunas). 2022 Dec 6;58(12):1794. doi: 10.3390/medicina58121794.
8
Evolving Role of Silodosin for the Treatment of Urological Disorders - A Narrative Review.索利那新在治疗泌尿系统疾病中的作用演变——一篇叙述性综述。
Drug Des Devel Ther. 2022 Aug 26;16:2861-2884. doi: 10.2147/DDDT.S373659. eCollection 2022.
9
Effect of perioperative selective alpha-1 blockers in non-stented ureteroscopic laser lithotripsy for ureteric stones: a randomized controlled trial.围手术期选择性α-1受体阻滞剂在非支架输尿管镜激光碎石治疗输尿管结石中的作用:一项随机对照试验
Cent European J Urol. 2020;73(4):520-525. doi: 10.5173/ceju.2020.0258. Epub 2020 Dec 14.
10
Alpha-blockers as medical expulsive therapy for ureteral stones.α受体阻滞剂作为输尿管结石的药物排石疗法
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD008509. doi: 10.1002/14651858.CD008509.pub3.